C9orf72 Amyotrophic Lateral Sclerosis (ALS)
Neurology·MeSH: Amyotrophic Lateral Sclerosis
Prevalence
5.0 / 100K
Incidence
2.0 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target C9orf72 Amyotrophic Lateral Sclerosis (ALS)?
There are 1 clinical trial targeting C9orf72 Amyotrophic Lateral Sclerosis (ALS) tracked by BioSniper.
What is the prevalence of C9orf72 Amyotrophic Lateral Sclerosis (ALS)?
The estimated prevalence of C9orf72 Amyotrophic Lateral Sclerosis (ALS) is approximately 5.0 per 100,000 population.
Deep-dive into C9orf72 Amyotrophic Lateral Sclerosis (ALS)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis